Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / COM
-
Number of holders
-
39
-
Total 13F shares, excl. options
-
19,605,364
-
Shares change
-
-187,834
-
Total reported value, excl. options
-
$28,234,677
-
Value change
-
-$885,274
-
Number of buys
-
9
-
Number of sells
-
-23
-
Price
-
$1.44
Significant Holders of AVADEL PHARMACEUTICALS - COM (AVDL) as of Q1 2019
52 filings reported holding AVDL - AVADEL PHARMACEUTICALS - COM as of Q1 2019.
AVADEL PHARMACEUTICALS - COM (AVDL) has 39 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19,605,364 shares
.
Largest 10 shareholders include BRANDES INVESTMENT PARTNERS, LP (7,052,720 shares), Broadfin Capital, LLC (3,102,673 shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (2,722,241 shares), BROWN CAPITAL MANAGEMENT LLC (1,400,007 shares), ACADIAN ASSET MANAGEMENT LLC (843,975 shares), Tekla Capital Management LLC (814,588 shares), MORGAN STANLEY (712,658 shares), RENAISSANCE TECHNOLOGIES LLC (658,336 shares), DEUTSCHE BANK AG\ (600,700 shares), and AMERIPRISE FINANCIAL INC (537,031 shares).
This table shows the top 39 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.